What Coronavirus Peak?
CDC Expects 200k COVID-19 Deaths By October As Dreaded 'Second Wave' Arrives: Live Updates
"Triple Threat": COVID-19, Ebola, Measles Outbreak In Congo
Scalia’s OSHA Is Not On Top Of COVID-19 Inspections
Macy’s Refuses To Protect Workers During Reopening: Union
States are making it harder to sue nursing homes over COVID-19: Why immunity from lawsuits is a problem
Workplaces are turning to devices to monitor social distancing, but does the tech respect privacy?
Novavax's COVID Vaccine Candidate Left off White House List; 5-Star Analyst Explains the Implications
After coronavirus, another hidden respiratory disease lurks in the buildings we left behind
What Is The Status Of Remote Work In The US Right Now?
Opening up US will trigger more COVID-19 cases, but disease models suggest how to avoid a second peak
Think Novavax Has Surged Enough for Now? Think Again, Says 5-Star Analyst
The 6-Feet Social Distancing Rule Can Kill You – Think Cobras
Pediatric scoring scale helps surgeons decide whether to operate during COVID-19 delays
How coronavirus could change air travel forever, but for good
Investors call for increased protections for meat processing workers
Donald Trump Wants To Cut The Funding For The WHO
Fight COVID-19 Deaths With Personal Responsibility
Is Royal Caribbean Cruises (RCL) Stock a Buy? This Analyst Says Yes
COVID-19 much more fatal for men, especially taking age into account
Skilled partners in the conduct of HIV prevention trials join COVID-19 response
Coronavirus Shakes Markets—Likely Temporarily
COVID-19: William Blair’s Proactive Response
Royal Caribbean Cruises Seeks $3.3 Billion Debt Sale, Moody’s Cuts Rating to Ba2 Junk Status
Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
Moderna CEO Stephane Bancel & Regeneron CEO Leonard Schleifer on a Coronavirus vaccine
Carnival Cruises Enjoys Huge Bookings Surge- Report
OSHA Citations Fall Nearly 70% During Pandemic
Congressional watchdog advises HHS to implement 'post-marketing' incentives to address dwindling antibiotic development efforts